NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,786,537 | -49.4% | 172,541 | +30.1% | 0.00% | -42.9% |
| Q2 2023 | $5,502,278 | +182.8% | 132,585 | +309.8% | 0.01% | +133.3% |
| Q1 2023 | $1,945,529 | -3.5% | 32,350 | +17.7% | 0.00% | 0.0% |
| Q4 2022 | $2,015,585 | -99.9% | 27,479 | -24.5% | 0.00% | -25.0% |
| Q3 2022 | $2,764,988,000 | -61.7% | 36,391 | -65.0% | 0.00% | -63.6% |
| Q2 2022 | $7,225,984,000 | +35.0% | 103,971 | +61.0% | 0.01% | +57.1% |
| Q1 2022 | $5,351,944,000 | -25.1% | 64,598 | -22.4% | 0.01% | -30.0% |
| Q4 2021 | $7,145,213,000 | +59.4% | 83,288 | +211.9% | 0.01% | +66.7% |
| Q3 2021 | $4,482,303,000 | -52.5% | 26,704 | -12.9% | 0.01% | -53.8% |
| Q2 2021 | $9,439,550,000 | +154.1% | 30,675 | +89.0% | 0.01% | +160.0% |
| Q1 2021 | $3,715,448,000 | -10.0% | 16,229 | -32.0% | 0.01% | -37.5% |
| Q4 2020 | $4,127,004,000 | +546.0% | 23,850 | +315.6% | 0.01% | +700.0% |
| Q3 2020 | $638,808,000 | -83.3% | 5,739 | -91.1% | 0.00% | -85.7% |
| Q2 2020 | $3,819,632,000 | +64.3% | 64,412 | +86.5% | 0.01% | +40.0% |
| Q1 2020 | $2,325,385,000 | -15.3% | 34,532 | +6.0% | 0.01% | 0.0% |
| Q4 2019 | $2,744,842,000 | +134.5% | 32,572 | +108.0% | 0.01% | +150.0% |
| Q3 2019 | $1,170,756,000 | +84.5% | 15,656 | +56.0% | 0.00% | +100.0% |
| Q2 2019 | $634,576,000 | -22.5% | 10,036 | -41.0% | 0.00% | -50.0% |
| Q1 2019 | $819,083,000 | +1361.4% | 17,004 | +915.8% | 0.00% | – |
| Q4 2018 | $56,046,000 | -73.6% | 1,674 | -58.7% | 0.00% | – |
| Q3 2018 | $212,534,000 | +87.5% | 4,056 | +12.0% | 0.00% | – |
| Q2 2018 | $113,369,000 | -58.0% | 3,622 | -70.8% | 0.00% | -100.0% |
| Q1 2018 | $270,211,000 | +11.5% | 12,395 | +3.3% | 0.00% | – |
| Q4 2017 | $242,400,000 | +78.2% | 12,000 | +75.1% | 0.00% | – |
| Q3 2017 | $136,052,000 | +8.8% | 6,854 | -5.2% | 0.00% | – |
| Q2 2017 | $125,062,000 | +1806.1% | 7,229 | +792.5% | 0.00% | – |
| Q1 2017 | $6,561,000 | -45.1% | 810 | -46.8% | 0.00% | – |
| Q4 2016 | $11,948,000 | -66.6% | 1,522 | -63.7% | 0.00% | – |
| Q3 2016 | $35,766,000 | +53.4% | 4,188 | +109.6% | 0.00% | – |
| Q2 2016 | $23,317,000 | +15980.7% | 1,998 | +19880.0% | 0.00% | – |
| Q1 2016 | $145,000 | -99.6% | 10 | -99.3% | 0.00% | – |
| Q4 2015 | $33,942,000 | – | 1,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |